Motley Fool  May 25  Comment 
An increase in EBITDA guidance doesn't necessarily mean this company's back on track.
FiercePharma  May 24  Comment 
Valeant Pharmaceuticals faced no shortage of arguments in the long dark night of controversy that's wreaked havoc on its stock price. Now, a new dispute is brewing with Johnson & Johnson over responsibility in talc lawsuits.
SeekingAlpha  May 23  Comment 
Motley Fool  May 23  Comment 
Valeant and Gilead Sciences' are arguably cheap stocks, but big questions remain that still make them risky to buy.
MarketWatch  May 22  Comment 
Eyegate Pharmaceuticals Inc. stock surged 11% in premarket trade Monday after the company said it had received its first milestone payment from Valeant Pharmaceuticals International Inc. resulting from a February licensing deal for Eyegate's...
SeekingAlpha  May 19  Comment 

You may also be interested in articles related to Valeant Pharmaceuticals International (VRX):


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki